%PDF-1.4
%
113 0 obj
<>
endobj
112 0 obj
<>stream
StampPDF Batch 2.7 for Solaris - SPDF 1045
2010-10-20T10:45:15Z
2010-10-28T03:22:54-07:00
2010-10-28T03:22:54-07:00
XPP
application/pdf
uuid:bfa9e737-1dd1-11b2-0a00-3e08274c7800
uuid:bfa9e73e-1dd1-11b2-0a00-10f600000000
dc:creator
dc:title
dc:description
endstream
endobj
110 0 obj
<>
endobj
104 0 obj
<>
endobj
115 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
111 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
109 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
108 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
107 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
106 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
105 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
103 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/TrimBox[9 9 594 792]/Type/Page>>
endobj
141 0 obj
[144 0 R]
endobj
142 0 obj
<>stream
q
359 0 0 170 129 259 cm
/Im0 Do
Q
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
11.5 0 0 11.5 145.3807 718.3835 Tm
(Disclosures)Tj
/T1_1 1 Tf
8.5 0 0 8.5 56.1648 707.8722 Tm
(None.)Tj
/T1_0 1 Tf
11.5 0 0 11.5 146.3523 686.3608 Tm
(References)Tj
/T1_1 1 Tf
7.5 0 0 7.5 59.9148 676.3495 Tm
[(1.)-500 (Lauer)-506.1 (GM,)-506.1 (Walker)-506.1 (BD.)-506.1 (Hepatitis)-506.1 (C)-506.1 (virus)-506.1 (infection.)]TJ
/T1_2 1 Tf
24.1565 0 Td
[(N)-506.1 (Engl)-506.1 (J)-506.1 (Med)]TJ
/T1_1 1 Tf
[0.1 (.)]TJ
-22.9065 -1.2015 Td
(2001;345:41\22652.)Tj
-1.25 -1.2015 Td
[(2.)-500 (Gumber)-395.5 (SC,)-395.5 (Chopra)-395.5 (S.)-395.5 (Hepatitis)-395.5 (C:)-395.5 (A)-395.5 (multifaceted)-395.5 (disease:)-395.5 (review)-395.5 (of)]TJ
1.25 -1.2015 Td
[(extrahepatic)-333 (manifestations.)]TJ
/T1_2 1 Tf
11.6359 0 Td
[(Ann)-333 (Intern)-333 (Med)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (1995;123:615\226)-119.7 (620.)]TJ
-12.8859 -1.2015 Td
[(3.)-500 (Poynard)-273.9 (T,)-273.9 (McHutchison)-273.9 (J,)-273.9 (Manns)-273.9 (M,)-273.9 (Trepo)-273.9 (C,)-273.9 (Lindsay)-273.9 (K,)-273.9 (Goodman)-273.9 (Z,)]TJ
1.25 -1.2015 Td
[(Ling)-240.2 (MH,)-240.2 (Albrecht)-240.2 (J.)-240.2 (Impact)-240.2 (of)-240.2 (pegylated)-240.2 (interferon)-240.2 (alfa-2b)-240.2 (and)-240.2 (ribavirin)]TJ
0 -1.2015 TD
[(on)-371.2 (liver)-371.2 (fibrosis)-371.2 (in)-371.2 (patients)-371.2 (with)-371.2 (chronic)-371.2 (hepatitis)-371.2 (C.)]TJ
/T1_2 1 Tf
22.1459 0 Td
(Gastroenterology)Tj
/T1_1 1 Tf
(.)Tj
-22.1459 -1.2015 Td
(2002;122:1303\2261313.)Tj
-1.25 -1.2015 Td
[(4.)-500 (Amin)-264 (J,)-264 (Law)-264 (MG,)-264 (Bartlett)-264 (M,)-264 (Kaldor)-264 (JM,)-264 (Dore)-264 (GJ.)-264 (Causes)-264 (of)-264 (death)-264 (after)]TJ
1.25 -1.2015 Td
[(diagnosis)-262.1 (of)-262.1 (hepatitis)-262.1 (b)-262.1 (or)-262.1 (hepatitis)-262.1 (C)-262.1 (infection:)-262.1 (a)-262.1 (large)-262.1 (community-based)]TJ
T*
[(linkage)-333 (study.)]TJ
/T1_2 1 Tf
6.0269 0 Td
(Lancet)Tj
/T1_1 1 Tf
[(.)-333 (2006;368:938)-119.7 (\226945.)]TJ
-7.2769 -1.2015 Td
[(5.)-500 (Murray)-470.8 (CJL,)-470.8 (Lopez)-470.8 (AD.)-470.8 (Mortality)-470.8 (by)-470.8 (cause)-470.8 (for)-470.8 (eight)-470.8 (regions)-470.8 (of)-470.8 (the)]TJ
1.25 -1.2015 Td
[(world:)-333 (global)-333 (burden)-333 (of)-333 (disease)-333 (study.)]TJ
/T1_2 1 Tf
16.0237 0 Td
(Lancet)Tj
/T1_1 1 Tf
[(.)-333 (1997;349:1269)-119.7 (\2261276.)]TJ
-17.2737 -1.2015 Td
[(6.)-500 (Sacco)-491.3 (RL,)-491.3 (Adams)-491.3 (R,)-491.3 (Albers)-491.3 (G,)-491.3 (Alberts)-491.3 (MJ,)-491.3 (Benavente)-491.3 (O,)-491.3 (Furie)-491.3 (K,)]TJ
1.25 -1.2015 Td
[(Goldstein)-287.1 (LB,)-287.1 (Gorelick)-287.1 (P,)-287.1 (Halperin)-287.1 (J,)-287.1 (Harbaugh)-287.1 (R,)-287.1 (Johnston)-287.1 (SC,)-287.1 (Katzan)]TJ
T*
[(I,)-462.5 (Kelly-Hayes)-462.5 (M,)-462.5 (Kenton)-462.5 (EJ,)-462.5 (Marks)-462.5 (M,)-462.5 (Schwamm)-462.5 (LH,)-462.5 (Tomsick)-462.5 (T.)]TJ
T*
[(Guidelines)-389.8 (for)-389.8 (prevention)-389.8 (of)-389.8 (stroke)-389.8 (in)-389.8 (patients)-389.8 (with)-389.8 (ischemic)-389.8 (stroke)-389.8 (or)]TJ
T*
[(transient)-327.3 (ischemic)-327.3 (attack\227a)-327.3 (statement)-327.3 (for)-327.3 (healthcare)-327.3 (professionals)-327.3 (from)]TJ
T*
[(the)-232.2 (American)-232.2 (Heart)-232.2 (Association/American)-232.2 (Stroke)-232.2 (Association)-232.2 (Council)-232.2 (on)]TJ
T*
[(Stroke\227)-119.7 (co-sponsored)-333.7 (by)-333.7 (the)-333.7 (Council)-333.7 (on)-333.7 (Cardiovascular)-333.7 (Radiology)-333.7 (and)]TJ
0 -1.2 TD
[(Intervention\227the)-293.6 (American)-293.6 (Academy)-293.6 (of)-293.6 (Neurology)-293.6 (affirms)-293.6 (the)-293.6 (value)-293.6 (of)]TJ
T*
[(this)-333 (guideline.)]TJ
/T1_2 1 Tf
6.0829 0 Td
(Stroke)Tj
/T1_1 1 Tf
[(.)-333 (2006;37:577\226)-119.7 (617.)]TJ
0.02271 Tc -7.3102 -1.2 Td
[(7.)-522.8 (Nieto)-575.4 (FJ.)-575.4 (Infections)-575.4 (and)-575.4 (atherosclerosis:)-575.4 (new)-575.4 (clues)-575.4 (from)-575.4 (an)-575.4 (old)]TJ
0 Tc 1.2273 -1.2 Td
(hypothesis?)Tj
/T1_2 1 Tf
5.055 0 Td
[(Am)-333 (J)-333 (Epidemiol)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (1998;148:937\226948.)]TJ
-6.305 -1.2 Td
[(8.)-500 (Libby)-333 (P.)-333 (Inflammation)-333 (in)-333 (atherosclerosis.)]TJ
/T1_2 1 Tf
18.5248 0 Td
(Nature)Tj
/T1_1 1 Tf
[(.)-333 (2002;420:868)-119.7 (\226)-119.7 (874.)]TJ
-18.5248 -1.2 Td
[(9.)-500 (Fukui)-268.9 (M,)-268.9 (Kitagawa)-268.9 (Y,)-268.9 (Nakamura)-268.9 (N,)-268.9 (Yoshikawa)-268.9 (T.)-268.9 (Hepatitis)-268.9 (C)-268.9 (virus)-268.9 (and)]TJ
0.01331 Tc 1.25 -1.2 Td
[(atherosclerosis)-565.9 (in)-565.9 (patients)-565.9 (with)-565.9 (type)-565.9 (2)-565.9 (diabetes.)]TJ
/T1_2 1 Tf
21.8904 0 Td
(JAMA)Tj
/T1_1 1 Tf
[0.2 (.)-565.9 (2003;289:)]TJ
0 Tc -21.8905 -1.2 Td
(1245\2261246.)Tj
-1.75 -1.2 Td
[(10.)-500 (Ishizaka)-344.7 (N,)-344.7 (Ishizaka)-344.7 (Y,)-344.7 (Takahashi)-344.7 (E,)-344.7 (Tooda)-344.7 (E,)-344.7 (Hashimoto)-344.7 (H,)-344.7 (Nagai)-344.7 (R,)]TJ
0.0045 Tc 1.75 -1.2 Td
[(Yamakado)-557.2 (M.)-557.2 (Association)-557.2 (between)-557.2 (hepatitis)-557.2 (C)-557.2 (virus)-557.2 (seropositivity,)]TJ
0 Tc T*
[(carotid-artery)-469.3 (plaque,)-469.3 (and)-469.3 (intima-media)-469.3 (thickening.)]TJ
/T1_2 1 Tf
21.9536 0 Td
(Lancet)Tj
/T1_1 1 Tf
[(.)-469.3 (2002;359:)]TJ
-21.9536 -1.2 Td
(133\226135.)Tj
-1.75 -1.2 Td
[(11.)-500 (Ishizaka)-268.9 (Y,)-268.9 (Ishizaka)-268.9 (N,)-268.9 (Takahashi)-268.9 (E,)-268.9 (Unuma)-268.9 (T,)-268.9 (Tooda)-268.9 (EI,)-268.9 (Hashimoto)-268.9 (H,)]TJ
1.75 -1.2 Td
[(Nagai)-538.6 (R,)-538.6 (Yamakado)-538.6 (M.)-538.6 (Association)-538.6 (between)-538.6 (hepatitis)-538.6 (C)-538.6 (virus)-538.6 (core)]TJ
T*
[(protein)-333 (and)-333 (carotid)-333 (atherosclerosis.)]TJ
/T1_2 1 Tf
14.5788 0 Td
[(Circ)-333 (J)]TJ
/T1_1 1 Tf
[(.)-333 (2003;67:26)-119.7 (\22630.)]TJ
-16.3288 -1.2 Td
[(12.)-500 (O\222Leary)-326.1 (DH,)-326.1 (Polak)-326.1 (JF,)-326.1 (Kronmal)-326.1 (RA,)-326.1 (Manolio)-326.1 (TA,)-326.1 (Burke)-326.1 (GL,)-326.1 (Wolfson)]TJ
1.75 -1.2 Td
[(SK.)-337.1 (Carotid-artery)-337.1 (intima)-337.1 (and)-337.1 (media)-337.1 (thickness)-337.1 (as)-337.1 (a)-337.1 (risk)-337.1 (factor)-337.1 (for)-337.1 (myo-)]TJ
T*
[(cardial)-399.6 (infarction)-399.6 (and)-399.6 (stroke)-399.6 (in)-399.6 (older)-399.6 (adults.)]TJ
/T1_2 1 Tf
18.7663 0 Td
[(N)-399.6 (Engl)-399.6 (J)-399.6 (Med)]TJ
/T1_1 1 Tf
[-0.1 (.)-399.6 (1999;340:)]TJ
-18.7663 -1.2 Td
[(14)-119.7 (\22622.)]TJ
-1.75 -1.2 Td
[(13.)-500 (Bruno)-273.5 (S,)-273.5 (Crosignani)-273.5 (A,)-273.5 (Maisonneuve)-273.5 (P,)-273.5 (Rossi)-273.5 (S,)-273.5 (Silini)-273.5 (E,)-273.5 (Mondelli)-273.5 (MU.)]TJ
1.75 -1.2 Td
[(Hepatitis)-470.8 (C)-470.8 (virus)-470.8 (genotype)-470.8 (1b)-470.8 (as)-470.8 (a)-470.8 (major)-470.8 (risk)-470.8 (factor)-470.8 (associated)-470.8 (with)]TJ
T*
[(hepatocellular)-541.7 (carcinoma)-541.7 (in)-541.7 (patients)-541.7 (with)-541.7 (cirrhosis:)-541.7 (a)-541.7 (seventeen-year)]TJ
T*
[(prospective)-333 (cohort)-333 (study.)]TJ
/T1_2 1 Tf
10.5809 0 Td
(Hepatology)Tj
/T1_1 1 Tf
[(.)-333 (2007;46:1350)-119.7 (\2261356.)]TJ
-12.3309 -1.2 Td
[(14.)-500 (Chen)-265.5 (CJ,)-265.5 (Yang)-265.5 (HI,)-265.5 (Su)-265.5 (J,)-265.5 (Jen)-265.5 (CL,)-265.5 (You)-265.5 (SL,)-265.5 (Lu)-265.5 (SN,)-265.5 (Huang)-265.5 (GT,)-265.5 (Iloeje)-265.5 (UH;)]TJ
1.75 -1.2 Td
[(REVEAL-HBV)-311 (Study)-311 (Group.)-311 (Risk)-311 (of)-311 (hepatocellular)-311 (carcinoma)-311 (across)-311 (a)]TJ
T*
[(biological)-362.1 (gradient)-362.1 (of)-362.1 (serum)-362.1 (hepatitis)-362.1 (b)-362.1 (virus)-362.1 (DNA)-362.1 (level.)]TJ
/T1_2 1 Tf
24.0621 0 Td
(JAMA.)Tj
/T1_1 1 Tf
3.1111 0 Td
(2006;)Tj
-27.1732 -1.2 Td
(295:65\22673.)Tj
-1.75 -1.2 Td
[(15.)-500 (Iloeje)-243.6 (UH,)-243.6 (Yang)-243.6 (HI,)-243.6 (Jen)-243.6 (CL,)-243.6 (Su)-243.6 (J,)-243.6 (Wang)-243.6 (LY,)-243.6 (You)-243.6 (SL,)-243.6 (Chen)-243.6 (CJ.)-243.6 (Risk)-243.6 (and)]TJ
1.75 -1.2 Td
[(predictors)-275.8 (of)-275.8 (mortality)-275.8 (associated)-275.8 (with)-275.8 (chronic)-275.8 (hepatitis)-275.8 (B)-275.8 (infection.)]TJ
/T1_2 1 Tf
27.7288 0 Td
(Clin)Tj
-27.7288 -1.2 Td
[(Gastroenterol)-333 (Hepatol)]TJ
/T1_1 1 Tf
[(.)-333 (2007;5:921\226931.)]TJ
-1.75 -1.2 Td
[(16.)-500 (Liu)-312.1 (CJ,)-312.1 (Chuang)-312.1 (WL,)-312.1 (Lee)-312.1 (CM,)-312.1 (Yu)-312.1 (ML,)-312.1 (Lu)-312.1 (SN,)-312.1 (Wu)-312.1 (SS,)-312.1 (Liao)-312.1 (LY,)-312.1 (Chew)]TJ
1.75 -1.2 Td
[(CL,)-318.2 (Kuo)-318.2 (HT,)-318.2 (Chao)-318.2 (YC,)-318.2 (Tung)-318.2 (SY,)-318.2 (Yang)-318.2 (SS,)-318.2 (Kao)-318.2 (JH,)-318.2 (Liu)-318.2 (CH,)-318.2 (Su)-318.2 (WW,)]TJ
T*
[(Lin)-233.3 (CL,)-233.3 (Jeng)-233.3 (YM,)-233.3 (Chen)-233.3 (PJ,)-233.3 (Chen)-233.3 (DS.)-233.3 (Peginterferon)-233.3 (alfa-2a)-233.3 (plus)-233.3 (ribavirin)]TJ
T*
[(for)-262.5 (the)-262.5 (treatment)-262.5 (of)-262.5 (dual)-262.5 (chronic)-262.5 (infection)-262.5 (with)-262.5 (hepatitis)-262.5 (B)-262.5 (and)-262.5 (C)-262.5 (viruses.)]TJ
/T1_2 1 Tf
T*
(Gastroenterology)Tj
/T1_1 1 Tf
[(.)-333 (2009;136:496)-119.7 (\226504.)]TJ
-1.75 -1.2 Td
[(17.)-500 (Yeh)-252.7 (SH,)-252.7 (Tsai)-252.7 (CY,)-252.7 (Kao)-252.7 (JH,)-252.7 (Liu)-252.7 (CJ,)-252.7 (Kuo)-252.7 (TJ,)-252.7 (Lin)-252.7 (MW,)-252.6 (Huang)-252.7 (WL,)-252.7 (Lu)-252.7 (SF,)]TJ
1.75 -1.2 Td
[(Jih)-372 (J,)-372 (Chen)-372 (DS,)-372 (Chen)-372 (PJ.)-372 (Quantification)-372 (and)-372 (genotyping)-372 (of)-372 (hepatitis)-372 (B)]TJ
T*
[(virus)-356.8 (in)-356.8 (a)-356.8 (single)-356.8 (reaction)-356.8 (by)-356.8 (real-time)-356.8 (PCR)-356.8 (and)-356.8 (melting)-356.8 (curve)-356.8 (analysis.)]TJ
/T1_2 1 Tf
T*
[(J)-333 (Hepatol)]TJ
/T1_1 1 Tf
[(.)-333 (2004;41:659)-119.7 (\226)-119.7 (666.)]TJ
-1.75 -1.2 Td
[(18.)-500 (Chen)-268.6 (CL,)-268.6 (Yang)-268.6 (HI,)-268.6 (Yang)-268.6 (WS,)-268.6 (Liu)-268.6 (CJ,)-268.6 (Chen)-268.6 (PJ,)-268.6 (You)-268.6 (SL,)-268.6 (Wang)-268.6 (LY,)-268.6 (Sun)]TJ
1.75 -1.2 Td
[(CA,)-380.7 (Lu)-380.7 (SN,)-380.7 (Chen)-380.7 (DS,)-380.7 (Chen)-380.7 (CJ.)-380.7 (Metabolic)-380.7 (factors)-380.7 (and)-380.7 (risk)-380.7 (of)-380.7 (hepato-)]TJ
T*
[(cellular)-322 (carcinoma)-322 (by)-322 (chronic)-322 (hepatitis)-322 (B/C)-322 (infection:)-322 (a)-322 (follow-up)-322 (study)]TJ
T*
[(in)-333 (Taiwan.)]TJ
/T1_2 1 Tf
4.6929 0 Td
(Gastroenterology)Tj
/T1_1 1 Tf
[(.)-333 (2008;135:111\226121.)]TJ
27.9571 80.3667 Td
[(19.)-500 (Fwu)-233.7 (CW,)-233.7 (Chien)-233.7 (YC,)-233.7 (Nelson)-233.7 (KE,)-233.7 (Kirk)-233.7 (GD,)-233.7 (You)-233.7 (SL,)-233.7 (Kuo)-233.7 (HS,)-233.7 (Feinleib)-233.7 (M,)]TJ
1.75 -1.1985 Td
[(Chen)-414.8 (CJ.)-414.8 (Mortality)-414.8 (after)-414.8 (chronic)-414.8 (hepatitis)-414.8 (B)-414.8 (virus)-414.8 (infection:)-414.8 (a)-414.8 (linkage)]TJ
0 -1.1985 TD
[(study)-489.8 (involving)-489.8 (2)-489.8 (million)-489.8 (parous)-489.8 (women)-489.8 (from)-489.8 (Taiwan.)]TJ
/T1_2 1 Tf
24.1122 0 Td
[(J)-489.8 (Infect)-489.8 (Dis)]TJ
/T1_1 1 Tf
[0.1 (.)]TJ
-24.1122 -1.1985 Td
[(2010;201:1016)-119.7 (\2261023.)]TJ
0.00079 Tc -1.75 -1.1985 Td
[(20.)-500.7 (Barba)-553.4 (C,)-553.4 (Cavalli-Sforza)-553.4 (T,)-553.4 (Cutter)-553.4 (J,)-553.4 (Darnton-Hill)-553.4 (I,)-553.4 (Deurenberg)-553.4 (P,)]TJ
0 Tc 1.75 -1.1985 Td
[(Deurenberg-Yap)-506.4 (M,)-506.4 (Gill)-506.4 (T,)-506.4 (James)-506.4 (P,)-506.4 (Ko)-506.4 (G,)-506.4 (Miu)-506.4 (AH,)-506.4 (Kosulwat)-506.4 (V,)]TJ
T*
[(Kumanyika)-298.5 (S,)-298.5 (Kurpad)-298.5 (A,)-298.5 (Mascie-Taylor)-298.5 (N,)-298.5 (Moon)-298.5 (HK,)-298.5 (Nishida)-298.5 (C,)-298.5 (Noor)]TJ
T*
[(MI,)-242 (Reddy)-242 (KS,)-242 (Rush)-242 (E,)-242 (Schultz)-242 (JT,)-242 (Seidell)-242 (J,)-242 (Stevens)-242 (J,)-242 (Swinburn)-242 (B,)-242.1 (Tan)]TJ
T*
[(K,)-317.8 (Weisell)-317.8 (R,)-317.8 (Wu)-317.8 (ZS,)-317.8 (Yajnik)-317.8 (CS,)-317.8 (Yoshiike)-317.8 (N,)-317.8 (Zimmet)-317.8 (P;)-317.8 (WHO)-317.8 (Expert)]TJ
T*
[(Consultation.)-268.6 (Appropriate)-268.6 (body-mass)-268.6 (index)-268.6 (for)-268.6 (Asian)-268.6 (populations)-268.6 (and)-268.6 (its)]TJ
T*
[(implications)-501.1 (for)-501.1 (policy)-501.1 (and)-501.1 (intervention)-501.1 (strategies.)]TJ
/T1_2 1 Tf
21.9218 0 Td
(Lancet)Tj
/T1_1 1 Tf
[(.)-501.1 (2004;363:)]TJ
-21.9218 -1.1985 Td
(157\226163.)Tj
-1.75 -1.1985 Td
[(21.)-500 (Marelli)-379.2 (D,)-379.2 (Bresson)-379.2 (J,)-379.2 (Laks)-379.2 (H,)-379.2 (Kubak)-379.2 (B,)-379.2 (Fonarow)-379.2 (G,)-379.2 (Tsai)-379.2 (FC,)-379.2 (Tran)-379.2 (J,)]TJ
1.75 -1.1985 Td
[(Weston)-365.5 (SR,)-365.5 (Kobashigawa)-365.5 (J.)-365.5 (Hepatitis)-365.5 (C-positive)-365.5 (donors)-365.5 (in)-365.5 (heart)-365.5 (trans-)]TJ
T*
(plantation.)Tj
/T1_2 1 Tf
4.583 0 Td
[(Am)-333 (J)-333 (Transplant)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2002;2:443\226)-119.7 (447.)]TJ
0.00529 Tc -6.333 -1.1985 Td
[(22.)-505.3 (Younossi)-558 (ZM,)-558 (Braun)-558 (WE,)-558 (Protiva)-558 (DA,)-558 (Gifford)-558 (RW,)-558 (Straffon)-558 (RA.)]TJ
0 Tc 1.75 -1.1985 Td
[(Chronic)-303.8 (viral)-303.8 (hepatitis)-303.8 (in)-303.8 (renal)-303.8 (transplant)-303.8 (recipients)-303.8 (with)-303.8 (allografts)-303.8 (func-)]TJ
T*
[(tioning)-333 (for)-333 (more)-333 (than)-333 (20)-333 (years.)]TJ
/T1_2 1 Tf
13.1347 0 Td
(Transplantation)Tj
/T1_1 1 Tf
[(.)-333 (1999;67:272\226275.)]TJ
-14.8847 -1.1985 Td
[(23.)-500 (Guiltinan)-450.4 (AM,)-450.4 (Kaidarova)-450.4 (Z,)-450.4 (Custer)-450.4 (B,)-450.4 (Orland)-450.4 (J,)-450.4 (Strollo)-450.4 (A,)-450.4 (Cyrus)-450.4 (S,)]TJ
1.75 -1.1985 Td
[(Busch)-316.3 (MP,)-316.3 (Murphy)-316.3 (EL.)-316.3 (Increased)-316.3 (all-cause,)-316.3 (liver,)-316.3 (and)-316.3 (cardiac)-316.3 (mortality)]TJ
T*
[(among)-515.2 (hepatitis)-515.1 (C)-515.2 (virus-seropositive)-515.2 (blood)-515.2 (donors.)]TJ
/T1_2 1 Tf
22.2849 0 Td
[(Am)-515.2 (J)-515.2 (Epidemiol)]TJ
/T1_1 1 Tf
[0.1 (.)]TJ
-22.2849 -1.1985 Td
(2008;167:743\226750.)Tj
-1.75 -1.1985 Td
[(24.)-500 (Arcari)-220.8 (CM,)-220.8 (Nelson)-220.8 (KE,)-220.8 (Netski)-220.8 (DM,)-220.8 (Nieto)-220.8 (FJ,)-220.8 (Gaydos)-220.8 (CA.)-220.8 (No)-220.8 (association)]TJ
1.75 -1.2 Td
[(between)-303.4 (hepatitis)-303.4 (C)-303.4 (virus)-303.4 (seropositivity)-303.4 (and)-303.4 (acute)-303.4 (myocardial)-303.4 (infarction.)]TJ
/T1_2 1 Tf
0 -1.2 TD
[(Clin)-333 (Infect)-333 (Dis)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2006;43:E53\226E56.)]TJ
-1.75 -1.2 Td
[(25.)-500 (Volzke)-420.1 (H,)-420.1 (Schwahn)-420.1 (C,)-420.1 (Wolff)-420.1 (B,)-420.1 (Mentel)-420.1 (R,)-420.1 (Robinson)-420.1 (DM,)-420.1 (Kleine)-420.1 (V,)]TJ
1.75 -1.2 Td
[(Felix)-470.8 (SB,)-470.8 (John)-470.8 (U.)-470.8 (Hepatitis)-470.8 (B)-470.8 (and)-470.8 (C)-470.8 (virus)-470.8 (infection)-470.8 (and)-470.8 (the)-470.8 (risk)-470.8 (of)]TJ
0.0144 Tc T*
[(atherosclerosis)-567 (in)-567 (a)-567 (general)-567 (population.)]TJ
/T1_2 1 Tf
17.9894 0 Td
(Atherosclerosis)Tj
/T1_1 1 Tf
[0.2 (.)-567 (2004;174:)]TJ
0 Tc -17.9894 -1.2 Td
[(99)-119.7 (\226103.)]TJ
-1.75 -1.2 Td
[(26.)-500 (Kiechl)-331.8 (S,)-331.8 (Egger)-331.8 (G,)-331.8 (Mayr)-331.8 (M,)-331.8 (Wiedermann)-331.8 (CJ,)-331.8 (Bonora)-331.8 (E,)-331.8 (Oberhollenzer)]TJ
1.75 -1.2 Td
[(F,)-311 (Muggeo)-311 (M,)-311 (Xu)-311 (QB,)-311 (Wick)-311 (G,)-311 (Poewe)-311 (W,)-311 (Willeit)-311 (J.)-311 (Chronic)-311 (infections)]TJ
T*
[(and)-347.3 (the)-347.4 (risk)-347.4 (of)-347.3 (carotid)-347.3 (atherosclerosis\227prospective)-347.3 (results)-347.3 (from)-347.4 (a)-347.3 (large)]TJ
T*
[(population)-333 (study.)]TJ
/T1_2 1 Tf
7.3609 0 Td
(Circulation)Tj
/T1_1 1 Tf
[(.)-333 (2001;103:1064)-119.7 (\2261070.)]TJ
-9.1109 -1.2 Td
[(27.)-500 (Espinola-Klein)-479.5 (C,)-479.5 (Rupprecht)-479.5 (HJ,)-479.5 (Blankenberg)-479.5 (S,)-479.5 (Bickel)-479.5 (C,)-479.6 (Kopp)-479.6 (H,)]TJ
1.75 -1.2 Td
[(Victor)-337.1 (A,)-337.1 (Hafner)-337.1 (G,)-337.1 (Prellwitz)-337.1 (W,)-337.1 (Schlumberger)-337.1 (W,)-337.1 (Meyer)-337.1 (J.)-337.1 (Impact)-337.1 (of)]TJ
T*
[(infectious)-272.4 (burden)-272.3 (on)-272.4 (progression)-272.3 (of)-272.3 (carotid)-272.3 (atherosclerosis.)]TJ
/T1_2 1 Tf
24.0964 0 Td
(Stroke)Tj
/T1_1 1 Tf
[(.)-272.3 (2002;)]TJ
-24.0964 -1.2 Td
(33:2581\2262586.)Tj
-1.75 -1.2 Td
[(28.)-500 (Smeeth)-369.7 (L,)-369.7 (Thomas)-369.7 (SL,)-369.7 (Hall)-369.7 (AJ,)-369.7 (Hubbard)-369.7 (R,)-369.7 (Farrington)-369.7 (P,)-369.7 (Vallance)-369.7 (P.)]TJ
1.75 -1.2 Td
[(Risk)-373.5 (of)-373.5 (myocardial)-373.5 (infarction)-373.5 (and)-373.5 (stroke)-373.5 (after)-373.5 (acute)-373.5 (infection)-373.5 (or)-373.5 (vacci-)]TJ
T*
(nation.)Tj
/T1_2 1 Tf
3.083 0 Td
[(N)-333 (Engl)-333 (J)-333 (Med)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2004;351:2611\2262618.)]TJ
-4.8329 -1.2 Td
[(29.)-500 (Hansson)-541.7 (GK.)-541.7 (Mechanisms)-541.7 (of)-541.7 (disease\227inflammation,)-541.7 (atherosclerosis,)]TJ
1.75 -1.2 Td
[(and)-333 (coronary)-333 (artery)-333 (disease.)]TJ
/T1_2 1 Tf
11.7998 0 Td
[(N)-333 (Engl)-333 (J)-333 (Med)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2005;352:1685\2261695.)]TJ
-13.5498 -1.2 Td
[(30.)-500 (Giordano)-243.2 (TP,)-243.2 (Henderson)-243.2 (L,)-243.2 (Landgren)-243.2 (O,)-243.2 (Chiao)-243.2 (EY,)-243.2 (Kramer)-243.2 (JR,)-243.2 (El-Serag)]TJ
1.75 -1.2 Td
[(H,)-306.8 (Engels)-306.8 (EA.)-306.8 (Risk)-306.8 (of)-306.8 (non-Hodgkin)-306.8 (lymphoma)-306.8 (and)-306.8 (lymphoproliferative)]TJ
T*
[(precursor)-251.1 (diseases)-251.1 (in)-251.1 (us)-251.1 (veterans)-251.1 (with)-251.1 (hepatitis)-251.1 (C)-251.1 (virus.)]TJ
/T1_2 1 Tf
22.3962 0 Td
(JAMA)Tj
/T1_1 1 Tf
[(.)-251.1 (2007;297:)]TJ
-22.3962 -1.2 Td
[(2010)-119.7 (\2262017.)]TJ
-1.75 -1.2 Td
[(31.)-500 (Sansonno)-438.6 (D,)-438.6 (Dammacco)-438.6 (F.)-438.6 (Hepatitis)-438.6 (C)-438.6 (virus,)-438.6 (cryoglobulinaemia,)-438.6 (and)]TJ
0.0224 Tc 1.75 -1.2 Td
[(vasculitis:)-574.9 (immune)-575 (complex)-574.9 (relations.)]TJ
/T1_2 1 Tf
17.5318 0 Td
[(Lancet)-575 (Infect)-575.1 (Dis)]TJ
/T1_1 1 Tf
7.8732 0 Td
[(.)-575.1 (2005;5:)]TJ
0 Tc -25.4051 -1.2 Td
(227\226236.)Tj
-1.75 -1.2 Td
[(32.)-500 (Pai)-237.1 (JK,)-237.1 (Pischon)-237.1 (T,)-237.1 (Ma)-237.1 (J,)-237.1 (Manson)-237.1 (JE,)-237.1 (Hankinson)-237.1 (SE,)-237.1 (Joshipura)-237.1 (K,)-237.1 (Curhan)]TJ
1.75 -1.2 Td
[(GC,)-479.5 (Rifai)-479.5 (N,)-479.5 (Cannuscio)-479.5 (CC,)-479.5 (Stampfer)-479.5 (MJ,)-479.5 (Rimm)-479.5 (EB.)-479.5 (Inflammatory)]TJ
T*
[(markers)-238.3 (and)-238.3 (the)-238.3 (risk)-238.3 (of)-238.3 (coronary)-238.3 (heart)-238.3 (disease)-238.3 (in)-238.3 (men)-238.3 (and)-238.3 (women.)]TJ
/T1_2 1 Tf
26.6581 0 Td
[(N)-238.3 (Engl)]TJ
-26.6581 -1.2 Td
[(J)-333 (Med)]TJ
/T1_1 1 Tf
[(.)-333 (2004;351:2599)-119.7 (\2262610.)]TJ
-1.75 -1.2 Td
[(33.)-500 (Werner)-302.3 (N,)-302.3 (Kosiol)-302.3 (S,)-302.3 (Schiegl)-302.3 (T,)-302.3 (Ahlers)-302.3 (P,)-302.3 (Walenta)-302.3 (K,)-302.3 (Link)-302.3 (A,)-302.3 (Bohm)-302.3 (M,)]TJ
1.75 -1.2 Td
[(Nickenig)-370.8 (G.)-370.8 (Circulating)-370.8 (endothelial)-370.8 (progenitor)-370.8 (cells)-370.8 (and)-370.8 (cardiovascular)]TJ
T*
(outcomes.)Tj
/T1_2 1 Tf
4.416 0 Td
[(N)-333 (Engl)-333 (J)-333 (Med)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2005;353:999)-119.7 (\2261007.)]TJ
-6.1659 -1.2 Td
[(34.)-500 (Wang)-433.7 (CS,)-433.7 (Wang)-433.7 (ST,)-433.7 (Yao)-433.7 (WJ,)-433.7 (Chang)-433.7 (TT,)-433.7 (Chou)-433.7 (P.)-433.7 (Hepatitis)-433.7 (C)-433.7 (virus)]TJ
1.75 -1.2 Td
[(infection)-334.1 (and)-334.1 (the)-334.1 (development)-334.1 (of)-334.1 (type)-334.1 (2)-334.1 (diabetes)-334.1 (in)-334.1 (a)-334.1 (community-based)]TJ
T*
[(longitudinal)-333 (study.)]TJ
/T1_2 1 Tf
7.9169 0 Td
[(Am)-333 (J)-333 (Epidemiol)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2007;166:196)-119.7 (\226203.)]TJ
-9.6669 -1.2 Td
[(35.)-500 (Marchioni)-384.5 (E,)-384.5 (Ceroni)-384.5 (M,)-384.5 (Erbetta)-384.5 (A,)-384.5 (Alfonsi)-384.5 (E,)-384.5 (Bottanelli)-384.5 (M,)-384.5 (Imbesi)-384.5 (F,)]TJ
1.75 -1.2 Td
[(Ricevuti)-408.3 (G.)-408.3 (Severe)-408.3 (acute)-408.3 (cerebrovascular)-408.3 (disease)-408.3 (revealing)-408.3 (hepatitis)-408.3 (C)]TJ
T*
[(virus)-478 (infection:)-478 (effectiveness)-478 (of)-478 (alpha-interferon.)]TJ
/T1_2 1 Tf
20.9682 0 Td
[(J)-478 (Neurol)]TJ
/T1_1 1 Tf
[(.)-478 (2002;249:)]TJ
-20.9682 -1.2 Td
(1111\2261113.)Tj
0.0072 Tc -1.75 -1.2 Td
[(36.)-507.2 (Forton)-559.8 (DM,)-559.8 (Allsop)-559.8 (JM,)-559.8 (Main)-559.8 (J,)-559.8 (Foster)-559.8 (GR,)-559.8 (Thomas)-559.8 (HC,)-559.8 (Taylor-)]TJ
0 Tc 1.75 -1.2 Td
[(Robinson)-445.5 (SD.)-445.5 (Evidence)-445.5 (for)-445.5 (a)-445.5 (cerebral)-445.5 (effect)-445.5 (of)-445.5 (the)-445.5 (hepatitis)-445.4 (C)-445.5 (virus.)]TJ
/T1_2 1 Tf
T*
(Lancet)Tj
/T1_1 1 Tf
[(.)-333 (2001;358:38)-119.7 (\22639.)]TJ
-1.75 -1.2 Td
[(37.)-500 (Forton)-345.1 (DM,)-345.1 (Taylor-Robinson)-345.1 (SD,)-345.1 (Thomas)-345.1 (HC.)-345.1 (Cerebral)-345.1 (dysfunction)-345.1 (in)]TJ
1.75 -1.2 Td
[(chronic)-333 (hepatitis)-333 (C)-333 (infection.)]TJ
/T1_2 1 Tf
12.1918 0 Td
[(J)-333 (Viral)-333 (Hepat)]TJ
/T1_1 1 Tf
[0.1 (.)-333 (2003;10:81\226)-119.7 (86.)]TJ
/T1_0 1 Tf
10 0 0 10 272.1534 752.3835 Tm
[(Lee)-332.9 (et)-332.9 (al)-2000 (HCV)-332.9 (Infection)-332.9 (and)-332.9 (Cerebrovascular)-332.9 (Disease)]TJ
/T1_3 1 Tf
27.1044 0 Td
(7)Tj
0 g
/RelativeColorimetric ri
/GS1 gs
/T1_4 1 Tf
9 0 0 9 321.1154 32 Tm
( by guest on October 28, 2010 )Tj
0 0 1 rg
/GS1 gs
-8.88699 0 Td
(stroke.ahajournals.org)Tj
0 g
/GS1 gs
-7.55399 0 Td
(Downloaded from )Tj
ET
endstream
endobj
44 0 obj
<>stream
JFIF ,, Exif MM * b j( 1 r2 i , , Adobe Photoshop CS Windows 2007:01:10 11:03:16 g &( . H H JFIF H H Adobe_CM Adobe d
L "
?
3 !1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw 5 !1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ? TI%)$IJI$RI$I%)$IJB8fA J@"^#ۏj`/07 V]No yAo)`AA [wtJGy ^KЗN@3[%,L\gNb#G@6KHJTI%)$ILeuu
oAxAЀ;U ѓ' ]ȡ15R`dJtYER^G%6.C,ߺ_ ~IM~Տ$z3*U_U[7>2(YuU ᣴ~lߡ0o,8})+Z#RUbVJ%wWgn